Phase I Trial: SABR and Ipilimumab-Letter CLINICAL CANCER RESEARCH Hiniker, S. M., Reddy, S. A., Swetter, S. M., Knox, S. J. 2017; 23 (1): 320

View details for DOI 10.1158/1078-0432.CCR-16-2495

View details for Web of Science ID 000393876300035